EssilorLuxottica set to acquire Optegra clinics
EssilorLuxottica and MidEuropa recently entered into an agreement that will allow EssilorLuxottica to acquire Optegra, building upon its med-tech strategy.
EssilorLuxottica and MidEuropa recently entered into an agreement that will allow EssilorLuxottica to acquire Optegra, building upon its med-tech strategy.
KIAWAH ISLAND, S.C. — Eyes implanted with a novel enhanced monofocal IOL achieved usable intermediate and near visual acuity while maintaining distance vision, according to…
Improved axial resolution allows clearer visualization of early atrophic changes, including iRORA vs cRORA differentiation, as shared at the Heidelberg 2025 International SPECTRALIS Symposium –…
From basal laminar deposits to foveal centering, a new framework refines what clinicians see—and what they treat—in outer retinal disease, as presented at the Heidelberg…
Harrow expects BYQLOVI to be commercially available in Q4 2025.
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.
Joana E. Andoh, MD, went from being a legislative intern in D.C. to an engaged YO advocate for the Academy. As the 2025 Robert A.…
Specific optical coherence tomography (OCT) biomarkers can significantly predict the likelihood of treatment failure with anti-VEGF agents in patients with diabetic macular edema (DME), according…
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.
There are subtle but significant differences in the morphology and biochemistry of the eye between men and women. These differences may affect disease susceptibility, symptoms…
Can’t sign in? Forgot your username? Can’t sign in? Forgot your password? Thank you for considering a SLACK Journal for your manuscript. SLACK publishes 13…